Skip to main content
Caplight Logo









Anatomiz3D

Anatomiz3D

Private
MumbaiHealthcare & Life Scienceshttps://anatomiz3d.com/

Last Round

Grant

Apr 15, 2021

Total Funding Raised

$62,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Anatomiz3D is a medical technology company that provides patient-specific 3D printing solutions, including anatomical models, surgical guides, and implants.

Sector

Healthcare & Life Sciences

Verticals

3D Printing, Medical Devices, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

medical 3D printingpatient-specific implantssurgical guidesanatomical modelssurgical planningcustom implantsmedical image segmentationpoint-of-care 3D printingmedtechprecision medicineCT to 3D modelcustom prostheticsorthopedic surgical planning

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anatomiz3D Comparables

Compare Anatomiz3D with similar companies based on industry and business-model similarity.

Anatomiz3D comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LUCID Implants
88%
Incredible AM Pvt Ltd
80%
AdiOrth MediTech
79%

Anatomiz3D Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 15, 2021
StrategicDec 31, 2018

Key People

Founding team and executive leadership

Firoza Kothari

Co-Founder & CTO

Founding Team

Sagar Shah

Co-Founder & CFO

Founding Team

Sohrab Kothari

Co-Founder And COO

Founding Team

Anatomiz3D Investors

Notable investors and investment history

Anatomiz3D investors
InvestorRounds
Innovation FactoryAccelerator
South Australian Landing Pad ProgramGrant
Health Innovation Hub (H2i) @ U of TAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 2632% MoM, from 38 to 1K.

  • Dec 9, 2025

    Monthly visitors grew 71% MoM.

Anatomiz3D Filings

Explore SEC and related filing metadata, where available.

Anatomiz3D filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Anatomiz3D's valuation, stock price, and market status.

Is Anatomiz3D a public or private company?

Anatomiz3D is a private company.

What is the current stock price of Anatomiz3D?

Anatomiz3D is a private company with no public stock price. No recent secondary market data is available.

How much is Anatomiz3D worth (valuation)?

Valuation information for Anatomiz3D is not publicly available.

Can I buy Anatomiz3D stock?

Anatomiz3D shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Anatomiz3D's last funding round?

Anatomiz3D's most recent funding round was Grant on April 15, 2021.

Who are the main investors in Anatomiz3D?

Key investors in Anatomiz3D include Innovation Factory, South Australian Landing Pad Program, Health Innovation Hub (H2i) @ U of T.

Will Anatomiz3D IPO soon?

No public IPO plans have been announced for Anatomiz3D.

How can I track Anatomiz3D secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anatomiz3D's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMumbai
Employee Range14
Year Founded2018
Last FundingApr 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?